From BigGo Finance · BigGo Finance · · 1m 20s
ST Xiangxue Restructuring Accepted by Court
Guangzhou Intermediate Court accepts *ST Xiangxue's restructuring, risking delisting with negative net assets of CNY 773 million.
In brief
Guangzhou Intermediate Court accepts *ST Xiangxue's restructuring, risking delisting with negative net assets of CNY 773 million. Guangdong pharmaceutical company *ST Xiangxue's restructuring was accepted by Guangzhou Intermediate Court, putting it at risk of delisting due to negative net assets of CNY 773 million…
Court Accepts Restructuring

Guangzhou Intermediate People's Court accepted restructuring applications filed by Guangzhou Rural Commercial Bank's Huangpu Branch and Guangzhou High-Tech Zone Financial Leasing.
Creditors Must File Claims
Creditors must file claims with administrators by December 18, 2026, with first creditors' meeting scheduled for December 19.
Five Years of Losses
Company reported cumulative losses exceeding cny 3.8 billion from 2021 to 2025, including cny 1.392 billion loss in 2025.
Negative Net Assets

Company reported negative net assets of cny 773 million at end of third quarter 2026.
Additional Delisting Risk
Shares face additional delisting risk warning starting November 20, 2026 if restructuring fails or net assets remain negative.
Restructuring Risks
Court acceptance does not guarantee success; failure could lead to bankruptcy and liquidation.
Delisting Conditions
Company could face delisting if net assets remain negative at end of fiscal 2026.
The key point
Guangdong pharmaceutical company *ST Xiangxue's restructuring was accepted by Guangzhou Intermediate Court, putting it at risk of delisting due to negative net assets of CNY 773 million.
Read the TL;DR — this story on one card.





